1. Home
  2. FOXX vs INTS Comparison

FOXX vs INTS Comparison

Compare FOXX & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOXX
  • INTS
  • Stock Information
  • Founded
  • FOXX 2017
  • INTS 2012
  • Country
  • FOXX United States
  • INTS United States
  • Employees
  • FOXX N/A
  • INTS N/A
  • Industry
  • FOXX
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • FOXX
  • INTS Health Care
  • Exchange
  • FOXX Nasdaq
  • INTS Nasdaq
  • Market Cap
  • FOXX 34.2M
  • INTS 33.4M
  • IPO Year
  • FOXX N/A
  • INTS 2023
  • Fundamental
  • Price
  • FOXX $4.53
  • INTS $2.23
  • Analyst Decision
  • FOXX
  • INTS Strong Buy
  • Analyst Count
  • FOXX 0
  • INTS 3
  • Target Price
  • FOXX N/A
  • INTS $8.50
  • AVG Volume (30 Days)
  • FOXX 1.8M
  • INTS 26.6K
  • Earning Date
  • FOXX 02-14-2025
  • INTS 03-13-2025
  • Dividend Yield
  • FOXX N/A
  • INTS N/A
  • EPS Growth
  • FOXX N/A
  • INTS N/A
  • EPS
  • FOXX N/A
  • INTS N/A
  • Revenue
  • FOXX $42,988,015.00
  • INTS N/A
  • Revenue This Year
  • FOXX N/A
  • INTS N/A
  • Revenue Next Year
  • FOXX N/A
  • INTS N/A
  • P/E Ratio
  • FOXX N/A
  • INTS N/A
  • Revenue Growth
  • FOXX 98.81
  • INTS N/A
  • 52 Week Low
  • FOXX $2.45
  • INTS $1.50
  • 52 Week High
  • FOXX $14.99
  • INTS $5.94
  • Technical
  • Relative Strength Index (RSI)
  • FOXX N/A
  • INTS 49.26
  • Support Level
  • FOXX N/A
  • INTS $1.84
  • Resistance Level
  • FOXX N/A
  • INTS $2.27
  • Average True Range (ATR)
  • FOXX 0.00
  • INTS 0.28
  • MACD
  • FOXX 0.00
  • INTS -0.01
  • Stochastic Oscillator
  • FOXX 0.00
  • INTS 56.36

About FOXX Foxx Development Holdings Inc. Common Stock

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

Share on Social Networks: